Seeking Alpha

Sanofi (SNY) extends its offer for the outstanding shares of Genzyme (GENZ) to April 1 from...

Sanofi (SNY) extends its offer for the outstanding shares of Genzyme (GENZ) to April 1 from March 16. Meanwhile, other biotech firms focused on rare diseases say the Sanofi-Genzyme deal puts many peers into play as takeover targets.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)